日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomimetic Membrane Interface Technologies for Detection and Isolation of CTCs and EVs: Advances and Opportunities in Liquid Biopsy

用于检测和分离循环肿瘤细胞和细胞外囊泡的仿生膜界面技术:液体活检的进展与机遇

Liu, Duo; Yu, Jie; Li, Jingxue; Chen, Yixue; Peng, Mengle; Xu, Yifan; Wu, Yongjun; Ding, Lihua; He, Sitian

BARD1 recognizes pre-rRNA for DNA damage repair and rRNA biogenesis

BARD1识别前体rRNA,用于DNA损伤修复和rRNA生物合成。

Huang, Huang; Wu, Duo; Yu, Xiaochun

Landscape of the Epstein-Barr virus-host chromatin interactome and gene regulation.

Epstein-Barr病毒-宿主染色质相互作用组和基因调控的图谱

Tian Simon Zhongyuan, Yang Yang, Ning Duo, Yu Ting, Gao Tong, Deng Yuqing, Fang Ke, Xu Yewen, Jing Kai, Huang Guangyu, Chen Gengzhan, Yin Pengfei, Li Yiming, Zeng Fuxing, Tian Ruilin, Zheng Meizhen

Chronic cerebral hypoperfusion-induced myelin loss in normal-appearing white matter correlates with cognitive decline: insights from moyamoya disease

慢性脑低灌注引起的正常外观白质髓鞘丢失与认知能力下降相关:来自烟雾病的启示

Yu, Xinfeng; Xu, Duo; Yu, Yannan; Hu, Junwen; Wang, Lin; Jiang, Biao; Zhang, Minming

Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics

脑转移瘤免疫治疗生物标志物:深入了解肿瘤微环境动态

Li, Mu; Zhang, Yi; Yu, Duo; Yu, Yaoyu; Ma, Wenxue

Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma

肿瘤微环境响应性纳米胶囊递送 CRISPR/Cas9 以重新编程肝癌细胞中的免疫抑制微环境

Lei He, Zhaozhao Li, Danjie Su, Haichen Du, Kuo Zhang, Wangqian Zhang, Shuning Wang, Fei Xie, Yueyuan Qiu, Shuangxin Ma, Gege Shi, Duo Yu, Xiaoying Lei, Weina Li, Meng Li, Zhaowei Wang, Jintao Gu, Yingqi Zhang

China nationwide landscape of 16 types inherited metabolic disorders: a retrospective analysis on 372,255 clinical cases

中国16种遗传性代谢疾病全国概况:372,255例临床病例的回顾性分析

Zhao, Beibei; Chen, Peichun; She, Xuhui; Chen, Xiuru; Ni, Zhou; Zhou, Duo; Yu, Zinan; Liu, Chang; Huang, Xinwen

The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells

Aurora 激酶 B 定位阻滞剂 LXY18 在恶性细胞中选择性引发有丝分裂灾难

Julia Kalashova, Chenglu Yang, Hongmei Li, Yan Long, Duo Yu, Ting Zhang, Xumei Liu, Namrta Choudhry, Qiong Shi, Thaddeus D Allen

MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma

MiR-10b-5p 削弱 TET2 介导的 PD-L1 转录抑制,从而促进胶质母细胞瘤的免疫逃避和肿瘤进展

Wei Du, Dayu Chen, Ke Wei, Duo Yu, Zhiqiang Gan, Guozheng Xu, Guojie Yao

Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma

TCR 模拟抗体在肝细胞癌癌症免疫治疗中的验证和前景

Chang Liu #, Hong Liu #, Moumita Dasgupta, Lance M Hellman, Xiaogang Zhang, Kai Qu, Hui Xue, Yun Wang, Fenling Fan, Qi Chang, Duo Yu, Linhu Ge, Yu Zhang, Ziyou Cui, Pengbo Zhang, Bradley Heller, Hongbing Zhang, Bingyin Shi, Brian M Baker, Cheng Liu